The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
Pilot Study: The Effects of Omega-3 Fatty Acids on Metabolic Syndrome and Vascular Structure in Metabolic Syndrome as Assessed by Carotid IMT
Sponsor: National Institutes of Health (NIH)
A EARLY_PHASE1 clinical study on Metabolic Syndrome X, this trial is ongoing. The trial is conducted by National Institutes of Health (NIH) and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status Phase 0
First recorded
Oct 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institutes of Health (NIH)
- Northwest Lipid Research Clinic
- Pfizer
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .